Literature DB >> 7654325

Expression of clusterin in cell differentiation and cell death.

H S Ahuja1, M Tenniswood, R Lockshin, Z F Zakeri.   

Abstract

Clusterin, originally isolated as testosterone-repressed prostate message-2 from regressing rat ventral prostate, has been identified with the process of active cell death (ACD). The clusterin gene product is a glycosylated dimer consisting of alpha and beta subunits, resulting from the 70-kilodalton preprotein. To determine its relationship with ACD, we have examined clusterin expression via in situ hybridization and immunohistochemistry. Clusterin message is detected in the supporting cells in both testes and ovaries and the protein surrounds the mature germ cells. The highest level of expression was found in the head region of the epididymis. Clusterin message is also detected in selected cells of uterine glands and ducts both in the normal and pregnant uterus. The expression of clusterin in the developing embryo is most abundant in the choroid plexus, inner ear, and epithelium of the eye. None of the cells in the testes, epididymis, or embryo that express clusterin are undergoing ACD. The expression of clusterin appears to correlate with cell remodelling or differentiation that occurs during these periods of development. However, in the female reproductive system, we found clusterin to be expressed in both differentiating as well as dying cells. These results suggest that clusterin may provide support for cells undergoing specific biochemical and (or) physical changes. Our results are consistent with the hypothesis that clusterin is an antiinflammatory agent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7654325     DOI: 10.1139/o94-070

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  7 in total

1.  Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.

Authors:  Victoria G Weis; Josane F Sousa; Bonnie J LaFleur; Ki Taek Nam; Jared A Weis; Paul E Finke; Nadia A Ameen; James G Fox; James R Goldenring
Journal:  Gut       Date:  2012-07-07       Impact factor: 23.059

2.  Identification of putative retinoic acid target genes downstream of mesenchymal Tbx1 during inner ear development.

Authors:  Dennis C Monks; Bernice E Morrow
Journal:  Dev Dyn       Date:  2012-02-01       Impact factor: 3.780

3.  Cytoplasmic Clusterin expression correlates with pancreatic neuroendocrine tumor size and pathological stage.

Authors:  Evita B Henderson-Jackson; Aejaz Nasir; Dung-Tsa Chen; Pushpa Nandyala; Julie Djeu; Jonathan Strosberg; Larry Kvols; Domenico Coppola
Journal:  Pancreas       Date:  2013-08       Impact factor: 3.327

4.  Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.

Authors:  S M Ho; I Leav; S Ghatak; F Merk; V S Jagannathan; K Mallery
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

5.  Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-alpha, cigarette smoking and anti-platelet treatment.

Authors:  Amalia E Yanni; George Agrogiannis; Christos Gkekas; Despina Perrea
Journal:  Lipids Health Dis       Date:  2014-04-23       Impact factor: 3.876

6.  Clusterin: full-length protein and one of its chains show opposing effects on cellular lipid accumulation.

Authors:  Suvarsha Rao Matukumalli; Ramakrishna Tangirala; C M Rao
Journal:  Sci Rep       Date:  2017-01-25       Impact factor: 4.379

7.  Development of a Label-Free Immunosensor for Clusterin Detection as an Alzheimer's Biomarker.

Authors:  Kamrul Islam; Samar Damiati; Jagriti Sethi; Ahmed Suhail; Genhua Pan
Journal:  Sensors (Basel)       Date:  2018-01-20       Impact factor: 3.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.